beta-alanine and c-peptide

beta-alanine has been researched along with c-peptide in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brand, CL; Cherrington, AD; Edgerton, DS; Everett-Grueter, CA; Jacobsen, LO; Kristensen, K; Larsen, MO; Neal, DW; Nishimura, E; Rivera, N; Rodewald, T1
Bergman, A; Erion, DM; Kazierad, DJ; Lee, DS; Rolph, T; Somayaji, V; Tan, B1

Trials

1 trial(s) available for beta-alanine and c-peptide

ArticleYear
Effects of multiple ascending doses of the glucagon receptor antagonist PF-06291874 in patients with type 2 diabetes mellitus.
    Diabetes, obesity & metabolism, 2016, Volume: 18, Issue:8

    Topics: Adult; Aged; Alanine Transaminase; Amino Acids; Aspartate Aminotransferases; beta-Alanine; Blood Glucose; C-Peptide; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Fasting; Female; Glucagon; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Pyrazoles; Receptors, Glucagon; Sulfonylurea Compounds

2016

Other Studies

1 other study(ies) available for beta-alanine and c-peptide

ArticleYear
A novel glucagon receptor antagonist, NNC 25-0926, blunts hepatic glucose production in the conscious dog.
    The Journal of pharmacology and experimental therapeutics, 2007, Volume: 321, Issue:2

    Topics: Aniline Compounds; Animals; beta-Alanine; C-Peptide; Dogs; Dose-Response Relationship, Drug; Female; Gluconeogenesis; Glucose; Glycogenolysis; Liver; Male; Receptors, Glucagon

2007